KERYX BIOPHARMACEUTICALS INC 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Jan 31, 2017
Insider Transaction Report
Form 4
Madison Greg
See Remarks
Transactions
- Sale
Common Stock
2017-01-30$4.65/sh−18,248$84,853→ 235,322 total
Footnotes (2)
- [F1]Sale of a total of 18,248 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 51,251 shares of restricted stock on January 27, 2017. Mr. Madison had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 118,790 shares of restricted stock.